|

ILB-2109 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Innolake Biopharm1

Indications

  • Classic Hodgkin Lymphoma1
  • Nasopharyngeal Carcinoma1
  • Soft Tissue Sarcoma1
  • Triple Negative Breast Cancer1
  • Endometrial Cancer1

Other1 trial

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.